 | • レポートコード：MRC2-11QY06719 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は胃運動障害治療薬のグローバル市場について調査・分析したレポートです。種類別（ベルセトラグ、イパモレリン、TD-8954、その他）市場規模、用途別（病院、クリニック、家庭用）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別胃運動障害治療薬の競争状況、市場シェア ・世界の胃運動障害治療薬市場：種類別市場規模 2015年-2020年（ベルセトラグ、イパモレリン、TD-8954、その他） ・世界の胃運動障害治療薬市場：種類別市場規模予測 2021年-2026年（ベルセトラグ、イパモレリン、TD-8954、その他） ・世界の胃運動障害治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック、家庭用） ・世界の胃運動障害治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、家庭用） ・北米の胃運動障害治療薬市場分析：米国、カナダ ・ヨーロッパの胃運動障害治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの胃運動障害治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の胃運動障害治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの胃運動障害治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Theravance, Inc.、Helsinn Healthcare S.A.、Concert Pharmaceuticals, Inc.、Targacept, Inc.、ChironWells GmbH ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Gastric Motility Disorder Drug Market
The global Gastric Motility Disorder Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Gastric Motility Disorder Drug Scope and Market Size
Gastric Motility Disorder Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastric Motility Disorder Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Gastric Motility Disorder Drug market is segmented into
Velusetrag
Ipamorelin
TD-8954
Others
Segment by Application, the Gastric Motility Disorder Drug market is segmented into
Hospital
Clinic
Home Use
Regional and Country-level Analysis
The Gastric Motility Disorder Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Gastric Motility Disorder Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Gastric Motility Disorder Drug Market Share Analysis
Gastric Motility Disorder Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gastric Motility Disorder Drug business, the date to enter into the Gastric Motility Disorder Drug market, Gastric Motility Disorder Drug product introduction, recent developments, etc.
The major vendors covered:
Theravance, Inc.
Helsinn Healthcare S.A.
Concert Pharmaceuticals, Inc.
Targacept, Inc.
ChironWells GmbH
…
1 Study Coverage
1.1 Gastric Motility Disorder Drug Product Introduction
1.2 Market Segments
1.3 Key Gastric Motility Disorder Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gastric Motility Disorder Drug Market Size Growth Rate by Type
1.4.2 Velusetrag
1.4.3 Ipamorelin
1.4.4 TD-8954
1.4.5 Others
1.5 Market by Application
1.5.1 Global Gastric Motility Disorder Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Use
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gastric Motility Disorder Drug Market Size, Estimates and Forecasts
2.1.1 Global Gastric Motility Disorder Drug Revenue 2015-2026
2.1.2 Global Gastric Motility Disorder Drug Sales 2015-2026
2.2 Global Gastric Motility Disorder Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Gastric Motility Disorder Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Gastric Motility Disorder Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Gastric Motility Disorder Drug Competitor Landscape by Players
3.1 Gastric Motility Disorder Drug Sales by Manufacturers
3.1.1 Gastric Motility Disorder Drug Sales by Manufacturers (2015-2020)
3.1.2 Gastric Motility Disorder Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Gastric Motility Disorder Drug Revenue by Manufacturers
3.2.1 Gastric Motility Disorder Drug Revenue by Manufacturers (2015-2020)
3.2.2 Gastric Motility Disorder Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gastric Motility Disorder Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gastric Motility Disorder Drug Revenue in 2019
3.2.5 Global Gastric Motility Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Gastric Motility Disorder Drug Price by Manufacturers
3.4 Gastric Motility Disorder Drug Manufacturing Base Distribution, Product Types
3.4.1 Gastric Motility Disorder Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastric Motility Disorder Drug Product Type
3.4.3 Date of International Manufacturers Enter into Gastric Motility Disorder Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastric Motility Disorder Drug Market Size by Type (2015-2020)
4.1.1 Global Gastric Motility Disorder Drug Sales by Type (2015-2020)
4.1.2 Global Gastric Motility Disorder Drug Revenue by Type (2015-2020)
4.1.3 Gastric Motility Disorder Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gastric Motility Disorder Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Gastric Motility Disorder Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Gastric Motility Disorder Drug Revenue Forecast by Type (2021-2026)
4.2.3 Gastric Motility Disorder Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gastric Motility Disorder Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Gastric Motility Disorder Drug Market Size by Application (2015-2020)
5.1.1 Global Gastric Motility Disorder Drug Sales by Application (2015-2020)
5.1.2 Global Gastric Motility Disorder Drug Revenue by Application (2015-2020)
5.1.3 Gastric Motility Disorder Drug Price by Application (2015-2020)
5.2 Gastric Motility Disorder Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Gastric Motility Disorder Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Gastric Motility Disorder Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Gastric Motility Disorder Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Gastric Motility Disorder Drug by Country
6.1.1 North America Gastric Motility Disorder Drug Sales by Country
6.1.2 North America Gastric Motility Disorder Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Gastric Motility Disorder Drug Market Facts & Figures by Type
6.3 North America Gastric Motility Disorder Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Gastric Motility Disorder Drug by Country
7.1.1 Europe Gastric Motility Disorder Drug Sales by Country
7.1.2 Europe Gastric Motility Disorder Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gastric Motility Disorder Drug Market Facts & Figures by Type
7.3 Europe Gastric Motility Disorder Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Gastric Motility Disorder Drug by Region
8.1.1 Asia Pacific Gastric Motility Disorder Drug Sales by Region
8.1.2 Asia Pacific Gastric Motility Disorder Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Gastric Motility Disorder Drug Market Facts & Figures by Type
8.3 Asia Pacific Gastric Motility Disorder Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Gastric Motility Disorder Drug by Country
9.1.1 Latin America Gastric Motility Disorder Drug Sales by Country
9.1.2 Latin America Gastric Motility Disorder Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Gastric Motility Disorder Drug Market Facts & Figures by Type
9.3 Central & South America Gastric Motility Disorder Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Gastric Motility Disorder Drug by Country
10.1.1 Middle East and Africa Gastric Motility Disorder Drug Sales by Country
10.1.2 Middle East and Africa Gastric Motility Disorder Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Gastric Motility Disorder Drug Market Facts & Figures by Type
10.3 Middle East and Africa Gastric Motility Disorder Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Theravance, Inc.
11.1.1 Theravance, Inc. Corporation Information
11.1.2 Theravance, Inc. Description and Business Overview
11.1.3 Theravance, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Theravance, Inc. Gastric Motility Disorder Drug Products Offered
11.1.5 Theravance, Inc. Related Developments
11.2 Helsinn Healthcare S.A.
11.2.1 Helsinn Healthcare S.A. Corporation Information
11.2.2 Helsinn Healthcare S.A. Description and Business Overview
11.2.3 Helsinn Healthcare S.A. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Products Offered
11.2.5 Helsinn Healthcare S.A. Related Developments
11.3 Concert Pharmaceuticals, Inc.
11.3.1 Concert Pharmaceuticals, Inc. Corporation Information
11.3.2 Concert Pharmaceuticals, Inc. Description and Business Overview
11.3.3 Concert Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Products Offered
11.3.5 Concert Pharmaceuticals, Inc. Related Developments
11.4 Targacept, Inc.
11.4.1 Targacept, Inc. Corporation Information
11.4.2 Targacept, Inc. Description and Business Overview
11.4.3 Targacept, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Targacept, Inc. Gastric Motility Disorder Drug Products Offered
11.4.5 Targacept, Inc. Related Developments
11.5 ChironWells GmbH
11.5.1 ChironWells GmbH Corporation Information
11.5.2 ChironWells GmbH Description and Business Overview
11.5.3 ChironWells GmbH Sales, Revenue and Gross Margin (2015-2020)
11.5.4 ChironWells GmbH Gastric Motility Disorder Drug Products Offered
11.5.5 ChironWells GmbH Related Developments
11.1 Theravance, Inc.
11.1.1 Theravance, Inc. Corporation Information
11.1.2 Theravance, Inc. Description and Business Overview
11.1.3 Theravance, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Theravance, Inc. Gastric Motility Disorder Drug Products Offered
11.1.5 Theravance, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Gastric Motility Disorder Drug Market Estimates and Projections by Region
12.1.1 Global Gastric Motility Disorder Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Gastric Motility Disorder Drug Revenue Forecast by Regions 2021-2026
12.2 North America Gastric Motility Disorder Drug Market Size Forecast (2021-2026)
12.2.1 North America: Gastric Motility Disorder Drug Sales Forecast (2021-2026)
12.2.2 North America: Gastric Motility Disorder Drug Revenue Forecast (2021-2026)
12.2.3 North America: Gastric Motility Disorder Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Gastric Motility Disorder Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Gastric Motility Disorder Drug Sales Forecast (2021-2026)
12.3.2 Europe: Gastric Motility Disorder Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Gastric Motility Disorder Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Gastric Motility Disorder Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Gastric Motility Disorder Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Gastric Motility Disorder Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Gastric Motility Disorder Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Gastric Motility Disorder Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Gastric Motility Disorder Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Gastric Motility Disorder Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Gastric Motility Disorder Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Gastric Motility Disorder Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Gastric Motility Disorder Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Gastric Motility Disorder Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Gastric Motility Disorder Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Gastric Motility Disorder Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastric Motility Disorder Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Gastric Motility Disorder Drug Market Segments
Table 2. Ranking of Global Top Gastric Motility Disorder Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gastric Motility Disorder Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Velusetrag
Table 5. Major Manufacturers of Ipamorelin
Table 6. Major Manufacturers of TD-8954
Table 7. Major Manufacturers of Others
Table 8. Global Gastric Motility Disorder Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Gastric Motility Disorder Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Gastric Motility Disorder Drug Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Gastric Motility Disorder Drug Sales Market Share by Regions (2015-2020)
Table 12. Global Gastric Motility Disorder Drug Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Gastric Motility Disorder Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Gastric Motility Disorder Drug Sales Share by Manufacturers (2015-2020)
Table 15. Global Gastric Motility Disorder Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Gastric Motility Disorder Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastric Motility Disorder Drug as of 2019)
Table 17. Gastric Motility Disorder Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Gastric Motility Disorder Drug Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Gastric Motility Disorder Drug Price (2015-2020) (USD/Pcs)
Table 20. Gastric Motility Disorder Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Gastric Motility Disorder Drug Product Type
Table 22. Date of International Manufacturers Enter into Gastric Motility Disorder Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Gastric Motility Disorder Drug Sales by Type (2015-2020) (K Pcs)
Table 25. Global Gastric Motility Disorder Drug Sales Share by Type (2015-2020)
Table 26. Global Gastric Motility Disorder Drug Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Gastric Motility Disorder Drug Revenue Share by Type (2015-2020)
Table 28. Gastric Motility Disorder Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Gastric Motility Disorder Drug Sales by Application (2015-2020) (K Pcs)
Table 30. Global Gastric Motility Disorder Drug Sales Share by Application (2015-2020)
Table 31. North America Gastric Motility Disorder Drug Sales by Country (2015-2020) (K Pcs)
Table 32. North America Gastric Motility Disorder Drug Sales Market Share by Country (2015-2020)
Table 33. North America Gastric Motility Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Gastric Motility Disorder Drug Revenue Market Share by Country (2015-2020)
Table 35. North America Gastric Motility Disorder Drug Sales by Type (2015-2020) (K Pcs)
Table 36. North America Gastric Motility Disorder Drug Sales Market Share by Type (2015-2020)
Table 37. North America Gastric Motility Disorder Drug Sales by Application (2015-2020) (K Pcs)
Table 38. North America Gastric Motility Disorder Drug Sales Market Share by Application (2015-2020)
Table 39. Europe Gastric Motility Disorder Drug Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Gastric Motility Disorder Drug Sales Market Share by Country (2015-2020)
Table 41. Europe Gastric Motility Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Gastric Motility Disorder Drug Revenue Market Share by Country (2015-2020)
Table 43. Europe Gastric Motility Disorder Drug Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Gastric Motility Disorder Drug Sales Market Share by Type (2015-2020)
Table 45. Europe Gastric Motility Disorder Drug Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Gastric Motility Disorder Drug Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Gastric Motility Disorder Drug Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Gastric Motility Disorder Drug Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Gastric Motility Disorder Drug Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Gastric Motility Disorder Drug Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Gastric Motility Disorder Drug Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Gastric Motility Disorder Drug Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Gastric Motility Disorder Drug Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Gastric Motility Disorder Drug Sales Market Share by Application (2015-2020)
Table 55. Latin America Gastric Motility Disorder Drug Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Gastric Motility Disorder Drug Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Gastric Motility Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Gastric Motility Disorder Drug Revenue Market Share by Country (2015-2020)
Table 59. Latin America Gastric Motility Disorder Drug Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Gastric Motility Disorder Drug Sales Market Share by Type (2015-2020)
Table 61. Latin America Gastric Motility Disorder Drug Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Gastric Motility Disorder Drug Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Gastric Motility Disorder Drug Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Gastric Motility Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Gastric Motility Disorder Drug Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Gastric Motility Disorder Drug Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Gastric Motility Disorder Drug Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Application (2015-2020)
Table 71. Theravance, Inc. Corporation Information
Table 72. Theravance, Inc. Description and Major Businesses
Table 73. Theravance, Inc. Gastric Motility Disorder Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Theravance, Inc. Product
Table 75. Theravance, Inc. Recent Development
Table 76. Helsinn Healthcare S.A. Corporation Information
Table 77. Helsinn Healthcare S.A. Description and Major Businesses
Table 78. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Helsinn Healthcare S.A. Product
Table 80. Helsinn Healthcare S.A. Recent Development
Table 81. Concert Pharmaceuticals, Inc. Corporation Information
Table 82. Concert Pharmaceuticals, Inc. Description and Major Businesses
Table 83. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Concert Pharmaceuticals, Inc. Product
Table 85. Concert Pharmaceuticals, Inc. Recent Development
Table 86. Targacept, Inc. Corporation Information
Table 87. Targacept, Inc. Description and Major Businesses
Table 88. Targacept, Inc. Gastric Motility Disorder Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Targacept, Inc. Product
Table 90. Targacept, Inc. Recent Development
Table 91. ChironWells GmbH Corporation Information
Table 92. ChironWells GmbH Description and Major Businesses
Table 93. ChironWells GmbH Gastric Motility Disorder Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. ChironWells GmbH Product
Table 95. ChironWells GmbH Recent Development
Table 96. Global Gastric Motility Disorder Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 97. Global Gastric Motility Disorder Drug Sales Market Share Forecast by Regions (2021-2026)
Table 98. Global Gastric Motility Disorder Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 99. Global Gastric Motility Disorder Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 100. North America: Gastric Motility Disorder Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 101. North America: Gastric Motility Disorder Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Europe: Gastric Motility Disorder Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. Europe: Gastric Motility Disorder Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Asia Pacific: Gastric Motility Disorder Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 105. Asia Pacific: Gastric Motility Disorder Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 106. Latin America: Gastric Motility Disorder Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. Latin America: Gastric Motility Disorder Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Middle East and Africa: Gastric Motility Disorder Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Middle East and Africa: Gastric Motility Disorder Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 111. Key Challenges
Table 112. Market Risks
Table 113. Main Points Interviewed from Key Gastric Motility Disorder Drug Players
Table 114. Gastric Motility Disorder Drug Customers List
Table 115. Gastric Motility Disorder Drug Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastric Motility Disorder Drug Product Picture
Figure 2. Global Gastric Motility Disorder Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Velusetrag Product Picture
Figure 4. Ipamorelin Product Picture
Figure 5. TD-8954 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Gastric Motility Disorder Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Home Use
Figure 11. Gastric Motility Disorder Drug Report Years Considered
Figure 12. Global Gastric Motility Disorder Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Gastric Motility Disorder Drug Sales 2015-2026 (K Pcs)
Figure 14. Global Gastric Motility Disorder Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Gastric Motility Disorder Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Gastric Motility Disorder Drug Sales Market Share by Region in 2019
Figure 17. Global Gastric Motility Disorder Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Gastric Motility Disorder Drug Revenue Market Share by Region in 2019
Figure 19. Global Gastric Motility Disorder Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Gastric Motility Disorder Drug Revenue in 2019
Figure 21. Gastric Motility Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Gastric Motility Disorder Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Gastric Motility Disorder Drug Sales Market Share by Type in 2019
Figure 24. Global Gastric Motility Disorder Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Gastric Motility Disorder Drug Revenue Market Share by Type in 2019
Figure 26. Global Gastric Motility Disorder Drug Market Share by Price Range (2015-2020)
Figure 27. Global Gastric Motility Disorder Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Gastric Motility Disorder Drug Sales Market Share by Application in 2019
Figure 29. Global Gastric Motility Disorder Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Gastric Motility Disorder Drug Revenue Market Share by Application in 2019
Figure 31. North America Gastric Motility Disorder Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Gastric Motility Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Gastric Motility Disorder Drug Sales Market Share by Country in 2019
Figure 34. North America Gastric Motility Disorder Drug Revenue Market Share by Country in 2019
Figure 35. U.S. Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Gastric Motility Disorder Drug Market Share by Type in 2019
Figure 40. North America Gastric Motility Disorder Drug Market Share by Application in 2019
Figure 41. Europe Gastric Motility Disorder Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Gastric Motility Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Gastric Motility Disorder Drug Sales Market Share by Country in 2019
Figure 44. Europe Gastric Motility Disorder Drug Revenue Market Share by Country in 2019
Figure 45. Germany Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Gastric Motility Disorder Drug Market Share by Type in 2019
Figure 56. Europe Gastric Motility Disorder Drug Market Share by Application in 2019
Figure 57. Asia Pacific Gastric Motility Disorder Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Gastric Motility Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Gastric Motility Disorder Drug Sales Market Share by Region in 2019
Figure 60. Asia Pacific Gastric Motility Disorder Drug Revenue Market Share by Region in 2019
Figure 61. China Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Gastric Motility Disorder Drug Market Share by Type in 2019
Figure 84. Asia Pacific Gastric Motility Disorder Drug Market Share by Application in 2019
Figure 85. Latin America Gastric Motility Disorder Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Gastric Motility Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Gastric Motility Disorder Drug Sales Market Share by Country in 2019
Figure 88. Latin America Gastric Motility Disorder Drug Revenue Market Share by Country in 2019
Figure 89. Mexico Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Gastric Motility Disorder Drug Market Share by Type in 2019
Figure 96. Latin America Gastric Motility Disorder Drug Market Share by Application in 2019
Figure 97. Middle East and Africa Gastric Motility Disorder Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Gastric Motility Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Gastric Motility Disorder Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Gastric Motility Disorder Drug Market Share by Type in 2019
Figure 108. Middle East and Africa Gastric Motility Disorder Drug Market Share by Application in 2019
Figure 109. North America Gastric Motility Disorder Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Gastric Motility Disorder Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Gastric Motility Disorder Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Gastric Motility Disorder Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Gastric Motility Disorder Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Gastric Motility Disorder Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Gastric Motility Disorder Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Gastric Motility Disorder Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Gastric Motility Disorder Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Gastric Motility Disorder Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
糖尿病性神経障害治療薬の世界市場（～2026年） A drug used to treat mental illness caused by diabetes Market Analysis and Insights: Global Diabetic Neurological Disorder Therapeutic Drug Market The global Diabetic Neurological Disorder Therapeutic Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CA…- 過食症治療薬の世界市場（～2026年） Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusuall…
- 胃抑制性ポリペプチド受容体の世界市場（～2026年） Market Analysis and Insights: Global Gastric Inhibitory Polypeptide Receptor Market The global Gastric Inhibitory Polypeptide Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gastric Inhibitory Polypeptide Rece…
- 胎児性アルコールスペクトラム障害（FASD）治療の世界市場（～2026年） Fetal alcohol spectrum disorder are the group of conditions occurring in new born with a wide range of disabilities. Fetal alcohol spectrum disorder treatment market is an evolving market owing to the gradual change in the lifestyle and increased alcohol consumption by pregnant women, eventually inc…
- 胃がん治療薬の世界市場（～2026年） Gastric cancer drugs are used to treat malignancies, or cancerous growths. The APAC region to account for the highest market share during the forecast period. Much of this region’s growth can be attributed to the increasing demand for better healthcare infrastructure, which results in its massive ma…